Description
OPEN MARKET PHARMACEUTICALS - NATIONAL
First action · last action
2013-07-02 · 2013-10-15
Transactions
3
First transaction's obligation
$1,761,074
Base + all options value (sum of deltas)
$23,550
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
6
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-07-02+$1,761,074= $1,761,074
- Mod P000012013-07-22+$0= $1,761,074
- Mod P000032013-10-15-$1,737,524= $23,550
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-07-02 | +$1,761,074 | $1,761,074 | OPEN MARKET PHARMACEUTICALS - NATIONAL |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2013-07-22 | +$0 | $1,761,074 | OPEN MARKET PHARMACEUTICALS - NATIONAL (MOD TO CHANGE NDCS) |
| Mod P00003· CHANGE ORDER | 2013-10-15 | −$1,737,524 | $23,550 | OPEN MARKET PHARMACEUTICALS - NATIONAL |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI M2AHN6XHZFZ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77026P0123 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $48,147 | FY2026 |
| 36C77026P0093 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $292,931 | FY2026 |
| 36C77026P0085 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $14,026 | FY2026 |
| 36C77026P0083 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $139,996 | FY2026 |
| 36C77026P0059 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C77025P0081 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $13,521 | FY2025 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25516F2420 | CSL BEHRING L.L.C. | 255-NETWORK CONTRACT OFFICE 15 | $5,811 | FY2016 |
| VA25516F2412 | BAYER HEALTHCARE PHARMACEUTICALS INC | 255-NETWORK CONTRACT OFFICE 15 | $51,581 | FY2016 |
| VA25516P2404 | MCKESSON PLASMA AND BIOLOGICS LLC | 255-NETWORK CONTRACT OFFICE 15 | $10,851 | FY2016 |
| VA25516J2221 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 | $187,797 | FY2016 |
| VA25516D0093 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 | $0 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA797M13P0693_3600_-NONE-_-NONE- · retrieved 2026-09-26.